Copyright
©The Author(s) 2015.
World J Gastroenterol. Jul 7, 2015; 21(25): 7754-7763
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7754
Published online Jul 7, 2015. doi: 10.3748/wjg.v21.i25.7754
Figure 3 Ezetimibe treatment attenuates triglycerides accumulation and induces autophagy in hepatocytes.
Hepatic triglyceride concentration (A) and mRNA (B) and protein expression (C and D) involved in autophagy were expressed as the mean ± SE. Experiments represent at least three independent experiments (n≥ 9). aP < 0.05, bP < 0.01, vs control; cP < 0.05, dP < 0.01, PA vs PA + Ez. ATG: Autophagy-related gene; Con: Control; Ez: Ezetimibe; GAPDH: Glyceraldehyde 3-phosphate dehydrogenase; PA: Palmitic acid; TG: Triglycerides.
- Citation: Chang E, Kim L, Park SE, Rhee EJ, Lee WY, Oh KW, Park SW, Park CY. Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats. World J Gastroenterol 2015; 21(25): 7754-7763
- URL: https://www.wjgnet.com/1007-9327/full/v21/i25/7754.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i25.7754